**4. Endoscopy after laparoscopy**

#### **4.1 Endoscopy in the treatment of bariatric surgery complications**

Morbid obesity and its complications became an endemic problem in most developed countries [29]. Laparoscopic bariatric surgery has gained popularity in the field of surgical treatment of obesity. Laparoscopic gastric bypass and laparoscopic adjustable gastric banding account for more than 50% of bariatric surgeries performed worldwide [30]. Endoscopy is a useful tool in assessing complications of bariatric surgeries in addition to its role in the initial assessment of these patients prior to surgery.

Stomal stenosis is the one of the most frequent complications after Laparoscopic Roux en Y Gastric Bypass ( RYGBP) [31]. Stomal stenosis occurs in 1-5% of patients undergoing Laparoscopic RYGBP [32-34]. Endoscopic dilation of the stomal stenosis has proven to be successful without the need of surgical revision. Ukleja et al performed endoscopic balloon dilation of the stomal stricture in 61 patients. Dilation was done in 1 to 5 sessions and it was successful in all patients without a need for surgical revision. However, the procedure was complicated by perforation in 2.2% of all dilations (3 patients) [35]. In another series by Go et al which included 38 patients with stomal stenosis after RYGBP, the success rate of endoscopic balloon dilation was 95% with a 3% complication rate [36]. Similar results were published by Peifer et al in their cohort of 43 patients, in which 2 endoscopic dilation sessions up to 15 mm were successful in 93% of the patients without any perforations[34].

Laparoscopic gastric banding (LGB) can be complicated with band erosion and band slippage in 1% and 4.9% of procedures performed, respectively [37]. Band erosion can be seen by endoscopy as a white ring in retroflexion in the stomach. Removal of the gastric band can be successfully done with endoscopy, especially if more than 50% of the band eroded through the wall of the stomach. Expectant management is advisable when less than 50% of the gastric band eroded through the stomach wall [38]. Successful removal of gastric bands was described in many case reports by cutting the thinnest part of the band using papillotome, mixed current Argon Plasma Coagulation or with scissors [39-41].

Choleithiasis and its related billiary complications are common after bariatric surgery [42]. Occasionally, the endoscopists will face the challenge of accessing the bypassed intestinal limb to the ampulla of vater in order to perform billiary procedures [43]. Many techniques have been described in order to access the ampulla of vater in this circumstance. Wright et al described their experience in 15 patients with RYGBP who underwent billiary interventions. Initially, forward-viewing colonoscope was used to explore the afferent limb to find the ampulla. Billiary cannulation with the use of the colonoscope was achieved in 2 patients. In the rest of the patients, a guidewire was left and duodenoscope was advanced over the guidewire to the ampulla. This technique was successful in two-thirds of the enrolled patients [44]. Another described technique includes the use of the double balloon enteroscopy for ERCP.The feasibility of this technique was illustrated in many case series with a success rate of 80-90% in cannulating the common bile duct (CBD) and a more than 60% success rate in performing therapeutic intervention of the biliary tract [45-47]. The use of double balloon enteroscopy offers the advantage of exploration of the afferent limb in less

[27]. This technique has many advantages in difficult cases of foreign body removal. Endoscopy provides trans-illumination of the stomach and help to localize the foreign body for laparoscopic removal. In addition, laparoscopy provides the opportunity to clean the

Morbid obesity and its complications became an endemic problem in most developed countries [29]. Laparoscopic bariatric surgery has gained popularity in the field of surgical treatment of obesity. Laparoscopic gastric bypass and laparoscopic adjustable gastric banding account for more than 50% of bariatric surgeries performed worldwide [30]. Endoscopy is a useful tool in assessing complications of bariatric surgeries in addition to its

Stomal stenosis is the one of the most frequent complications after Laparoscopic Roux en Y Gastric Bypass ( RYGBP) [31]. Stomal stenosis occurs in 1-5% of patients undergoing Laparoscopic RYGBP [32-34]. Endoscopic dilation of the stomal stenosis has proven to be successful without the need of surgical revision. Ukleja et al performed endoscopic balloon dilation of the stomal stricture in 61 patients. Dilation was done in 1 to 5 sessions and it was successful in all patients without a need for surgical revision. However, the procedure was complicated by perforation in 2.2% of all dilations (3 patients) [35]. In another series by Go et al which included 38 patients with stomal stenosis after RYGBP, the success rate of endoscopic balloon dilation was 95% with a 3% complication rate [36]. Similar results were published by Peifer et al in their cohort of 43 patients, in which 2 endoscopic dilation sessions up to 15 mm were successful in 93% of the patients without any perforations[34]. Laparoscopic gastric banding (LGB) can be complicated with band erosion and band slippage in 1% and 4.9% of procedures performed, respectively [37]. Band erosion can be seen by endoscopy as a white ring in retroflexion in the stomach. Removal of the gastric band can be successfully done with endoscopy, especially if more than 50% of the band eroded through the wall of the stomach. Expectant management is advisable when less than 50% of the gastric band eroded through the stomach wall [38]. Successful removal of gastric bands was described in many case reports by cutting the thinnest part of the band using

papillotome, mixed current Argon Plasma Coagulation or with scissors [39-41].

Choleithiasis and its related billiary complications are common after bariatric surgery [42]. Occasionally, the endoscopists will face the challenge of accessing the bypassed intestinal limb to the ampulla of vater in order to perform billiary procedures [43]. Many techniques have been described in order to access the ampulla of vater in this circumstance. Wright et al described their experience in 15 patients with RYGBP who underwent billiary interventions. Initially, forward-viewing colonoscope was used to explore the afferent limb to find the ampulla. Billiary cannulation with the use of the colonoscope was achieved in 2 patients. In the rest of the patients, a guidewire was left and duodenoscope was advanced over the guidewire to the ampulla. This technique was successful in two-thirds of the enrolled patients [44]. Another described technique includes the use of the double balloon enteroscopy for ERCP.The feasibility of this technique was illustrated in many case series with a success rate of 80-90% in cannulating the common bile duct (CBD) and a more than 60% success rate in performing therapeutic intervention of the biliary tract [45-47]. The use of double balloon enteroscopy offers the advantage of exploration of the afferent limb in less

peritoneal spillage and ensure the closure of the abdominal wall [28].

**4.1 Endoscopy in the treatment of bariatric surgery complications** 

role in the initial assessment of these patients prior to surgery.

**4. Endoscopy after laparoscopy** 

240

time;, however, the lack of elevator could be problematic in gaining deep access of the CBD, especially in patients with naive papilla. Another novel technique utilizes the creation of a gastrostomy tube by an interventional radiologist in the excluded part of the stomach followed by the use of an ERCP endoscope through the gastrostomy[48]. Although this technique enables the use of an ERCP endoscope, it requires delaying the ERCP until maturation of the gastrostomy tube. A new technique of laparoscopic-assisted ERCP was proven to be successful in RYGBP patients [49]. Initially, a laparoscopic examination is done, followed by identification of the stomach remnant to create gastrostomy as an access for the ERCP endoscope. The endoscope is inserted through trochar from the abdominal wall to the gastrostomy opening and then to the biliary tract. This technique was successful in 9 out of 10 patients included in the study by Lopes et al. These impressive results were confirmed by Bertin et al, in which successful biliary cannulation was achieved in 94% of 21 RYGBP patients who underwent laparoscopic assisted ERCP [50]. In conclusion, bariatric surgeries are increasing due to the obesity epidemic. Endoscopists will have a major role in either evaluating these patients prior to surgery or in treating post-surgical complications.

#### **4.2 Endoscopy in treatment of post-surgical leaks and fistulas**

Anastomotic leaks are one of the major complications after gastrointestinal surgery. After laparoscopic RYGBP, anastomotic leaks can develop in 0.3 to 8% of patients[51]. Traditionally these leaks were managed surgically. The introduction of self-expandable removable stents offered a less invasive approach for management of anastomotic leak. In a retrospective study that included 5 patients with anastomotic leak and one patient with chronic gastrocutaneous fistula; self-expandable plastic stent was successful in closing the leak in all 5 patients but not in the patient with the fistula [52]. In another retrospective study that included 11 patients with acute leak and 2 patients with chronic fistula as a complication of bariatric surgery, self-expandable removal stents (metal and plastic) were successful in healing the acute leak in 89% of patients and one of the two patients with chronic fistula [53]. A new endoscopic device named "over the scope clip(OSC)," which utilizes a combination of clip with grasper and large suction cap to ensure serosa to serosa closure, was recently introduced to clinical practice. The new system has been evaluated in 12 patients with post-operative leaks or fistula with successful closure in 10 patients [54]. Currently, this system is approved in Europe but is not yet available for clinical use in United States. The recently published experiences of the use of this new OSC in different applications such as leaks, fistula and perforation are extremely encouraging [54-57].

#### **5. Endoscopy as an alternative to laparoscopy**

The recent advances in therapeutic endoscopy opened a new frontier for endoscopists to manage complicated clinical scenarios that were only managed surgically in the past. In this section we are going to discuss a few examples of the use of endoscopy in these clinical scenarios where surgery is contraindicated or considered a more invasive approach.

#### **5.1 Endoscopic gallbladder drainage**

Cholecystectomy (mainly by laparoscopic approach) is the standard of care for management of acute cholecystitis. In high risk patients for surgery percutaneous cholecystostomy is advocated as a temporarizing measure [58]. However, this approach could be problematic in patients with coagulopathy or due to anatomical reasons. In addition, an indwelling catheter

Role of Endoscopy in Laparoscopic Procedures

are not yet available for this new approach.

**6. References** 

endoscopic myotomy in the United States was reported in December 2010 by Stavropoulos et al; the procedure was successful with improvement in dysphagia in the follow-up period [73]. This technique has many advantages including the minimally invasive nature of the procedure, the lower incidence of reflux since only an incision of the circular muscle is done and the option of performing laparoscopic myotomy if needed. However, long-term data

[1] Feingold, D.L., et al., *Safety and reliability of tattooing colorectal neoplasms prior to* 

[2] Lane, K.L., et al., *Endoscopic tattoo agents in the colon. Tissue responses and clinical* 

[3] Price, N., et al., *Safety and efficacy of India ink and indocyanine green as colonic tattooing* 

[4] Yeung, J.M., C. Maxwell-Armstrong, and A.G. Acheson, *Colonic tattooing in laparoscopic* 

[5] Nizam, R., et al., *Colonic tattooing with India ink: benefits, risks, and alternatives*. Am J

[6] Askin, M.P., et al., *Tattoo of colonic neoplasms in 113 patients with a new sterile carbon* 

[7] Shatz, B.A., et al., *Long-term safety of India ink tattoos in the colon*. Gastrointest Endosc,

[8] Singh, S., et al., *Complication after pre-operative India ink tattooing in a colonic lesion.* Dig

[9] Lennon, A.M., et al., *EUS-guided tattooing before laparoscopic distal pancreatic resection (with* 

[10] Newman, N.A., et al., *Preoperative endoscopic tattooing of pancreatic body and tail lesions* 

[11] Vezakis, A., et al., *Intraoperative cholangiography during laparoscopic cholecystectomy.* Surg

[12] Clayton, E.S., et al., *Meta-analysis of endoscopy and surgery versus surgery alone for common bile duct stones with the gallbladder in situ*. Br J Surg, 2006. 93(10): p. 1185-91. [13] Kharbutli, B. and V. Velanovich, *Management of preoperatively suspected choledocholithiasis:* 

[14] Enochsson, L., et al., I*ntraoperative endoscopic retrograde cholangiopancreatography (ERCP)* 

*prolong hospitalization: a 2-year experience.* Surg Endosc, 2004. 18(3): p. 367-71. [15] ElGeidie, A.A., G.K. ElEbidy, and Y.M. Naeem, *Preoperative versus intraoperative* 

[16] Grunhagen, D.J., et al., *Laparoscopic-monitored colonoscopic polypectomy: a multimodality* 

[17] Franklin, M.E., Jr., et al., *Laparoscopic-assisted colonoscopic polypectomy: the Texas Endosurgery Institute experience.* Dis Colon Rectum, 2000. 43(9): p. 1246-9.

*to remove common bile duct stones during routine laparoscopic cholecystectomy does not* 

*endoscopic sphincterotomy for management of common bile duct stones.* Surg Endosc,

*a decision analysis*. J Gastrointest Surg, 2008. 12(11): p. 1973-80.

*method to avoid segmental colon resection*. Colorectal Dis, 2010.

*decreases operative time for laparoscopic distal pancreatectomy.* Surgery, 2010. 148(2): p.

*laparoscopic resection*. J Gastrointest Surg, 2004. 8(5): p. 543-6.

*surgery - making the mark?* Colorectal Dis, 2009. 11(5): p. 527-30.

*implications.* Am J Surg Pathol, 1996. 20(10): p. 1266-70.

*agents*. Gastrointest Endosc, 2000. 51(4 Pt 1): p. 438-42.

*compound.* Gastrointest Endosc, 2002. 56(3): p. 339-42.

*video)*. Gastrointest Endosc, 2010. 72(5): p. 1089-94.

Gastroenterol, 1996. 91(9): p. 1804-8.

1997. 45(2): p. 153-6.

371-7.

Surg, 2006. 23(5-6): p. 303.

Endosc, 2000. 14(12): p. 1118-22.

2011. 25(4): p. 1230-7.

243

is predisposed to infection and it reduces the quality of life. Endoscopic transpapillary drainage was introduced as a more attractive approach in this subset of patients. The technique utilizes the ERCP endoscope to cannulate the billiary tree and the cystic duct followed by placement of cystic duct stent or a nasocholecystic catheter in the gallbladder [59, 60]. The outcome of this endoscopic approach was evaluated retrospectively in 35 surgically high-risk patients with acute cholecystitis. Nasocholecystic catheter was inserted in 21 patients, plastic stent in 6 patients and combined approach in 2 patients. The procedure was not successful in 6 of the 35 patients (17 %). Among the 29 patients with successful gallbladder drainage, 24 patients clinically improved within 3 days, while 4 patients died of septic complications. Although this technique was successful in 83 % of the patients, longterm follow-up showed a 20% relapse rate for acute pancreatitis which emphasizes the role of this approach as a bridge until the patient is surgically fit [61].

#### **5.2 Endoscopic treatment of GERD**

Endoscopic treatment of GERD has been an attractive topic for the last 15 years. Hope for a successful cure of GERD with endoscopy has been a rollercoaster. In this section we will briefly discuss various endoscopic modalities currently available for GERD treatment. One of the earliest devices to treat GERD by endoscopic approach is the "Stretta Device". This device uses thermal coaogulation of the mucosa of the lower esophageal sphincter (LES) in order to narrow the esophagus and prevent GERD. Although the device showed modest success, its clinical use was hindered by the higher rate of complications such as esophageal perforation and aspiration pneumonia. Currently this system is not commercially available [62, 63]. Other devices utilize suturing techniques to produce endoscopic plication of the LES in an effort to decrease GERD. There are more than five plicator devices available in the market. There are multiple cases series and non-randomized trials investigating the effectiveness of this technique. In summary, it showed a modest decrease in acid reflux but the procedure is lengthy and there is an increased risk of complication [64-66]. Based on the available data, it is premature to support incorporating these devices in clinical practice. A third technique that involves injecting bulking agents at the LES to prevent GERD has been recently introduced. The injected materials are either plexigal microsphere or ethylene vinyl alcohol (biodegradable microsphere) as in the Enteryx device. Although the technique is easy to use, the Enteryx device was recalled by the United States' Food and Drug Administration due to the associated complications such esophageal abscess, polymer migration and death [67-69]. Although many of the above mentioned results are disappointing, there are other devices currently being researched which could alter the current grim look for use of endoscopy in GERD.

#### **5.3 Endoscopic myotomy for esophageal achalasia**

Traditionally, the endoscopy role in achalasia was limited to endoscopic dilation and endoscopic injection of BOTOX [70]. A new technique involving creating a submucosal tunnel in the lower esophagus followed by advancing the endoscope in the new created space to the lower esophageal sphincter (LES) and electrocautery disruption of circular muscle of LES was proven feasible in an animal model [71]. This technique was proven successful in 17 patients with achalasia who underwent endoscopic myotomy in a tertiary referral center in Japan. Patients had significant improvement of their dysphagia and in the resting LES pressure. No major complications were reported [72]. The first case of endoscopic myotomy in the United States was reported in December 2010 by Stavropoulos et al; the procedure was successful with improvement in dysphagia in the follow-up period [73]. This technique has many advantages including the minimally invasive nature of the procedure, the lower incidence of reflux since only an incision of the circular muscle is done and the option of performing laparoscopic myotomy if needed. However, long-term data are not yet available for this new approach.

#### **6. References**

Updated Topics in Minimally Invasive Abdominal Surgery

is predisposed to infection and it reduces the quality of life. Endoscopic transpapillary drainage was introduced as a more attractive approach in this subset of patients. The technique utilizes the ERCP endoscope to cannulate the billiary tree and the cystic duct followed by placement of cystic duct stent or a nasocholecystic catheter in the gallbladder [59, 60]. The outcome of this endoscopic approach was evaluated retrospectively in 35 surgically high-risk patients with acute cholecystitis. Nasocholecystic catheter was inserted in 21 patients, plastic stent in 6 patients and combined approach in 2 patients. The procedure was not successful in 6 of the 35 patients (17 %). Among the 29 patients with successful gallbladder drainage, 24 patients clinically improved within 3 days, while 4 patients died of septic complications. Although this technique was successful in 83 % of the patients, longterm follow-up showed a 20% relapse rate for acute pancreatitis which emphasizes the role

Endoscopic treatment of GERD has been an attractive topic for the last 15 years. Hope for a successful cure of GERD with endoscopy has been a rollercoaster. In this section we will briefly discuss various endoscopic modalities currently available for GERD treatment. One of the earliest devices to treat GERD by endoscopic approach is the "Stretta Device". This device uses thermal coaogulation of the mucosa of the lower esophageal sphincter (LES) in order to narrow the esophagus and prevent GERD. Although the device showed modest success, its clinical use was hindered by the higher rate of complications such as esophageal perforation and aspiration pneumonia. Currently this system is not commercially available [62, 63]. Other devices utilize suturing techniques to produce endoscopic plication of the LES in an effort to decrease GERD. There are more than five plicator devices available in the market. There are multiple cases series and non-randomized trials investigating the effectiveness of this technique. In summary, it showed a modest decrease in acid reflux but the procedure is lengthy and there is an increased risk of complication [64-66]. Based on the available data, it is premature to support incorporating these devices in clinical practice. A third technique that involves injecting bulking agents at the LES to prevent GERD has been recently introduced. The injected materials are either plexigal microsphere or ethylene vinyl alcohol (biodegradable microsphere) as in the Enteryx device. Although the technique is easy to use, the Enteryx device was recalled by the United States' Food and Drug Administration due to the associated complications such esophageal abscess, polymer migration and death [67-69]. Although many of the above mentioned results are disappointing, there are other devices currently being researched which could alter the

Traditionally, the endoscopy role in achalasia was limited to endoscopic dilation and endoscopic injection of BOTOX [70]. A new technique involving creating a submucosal tunnel in the lower esophagus followed by advancing the endoscope in the new created space to the lower esophageal sphincter (LES) and electrocautery disruption of circular muscle of LES was proven feasible in an animal model [71]. This technique was proven successful in 17 patients with achalasia who underwent endoscopic myotomy in a tertiary referral center in Japan. Patients had significant improvement of their dysphagia and in the resting LES pressure. No major complications were reported [72]. The first case of

of this approach as a bridge until the patient is surgically fit [61].

**5.2 Endoscopic treatment of GERD** 

current grim look for use of endoscopy in GERD.

**5.3 Endoscopic myotomy for esophageal achalasia** 


Role of Endoscopy in Laparoscopic Procedures

1254-9.

600.

183(1): p. 193-6.

*technique.* Surg Endosc, 2011.

[39] Meyenberger, C., C. Gubler, and P.M. Hengstler, *Endoscopic management of a penetrated* 

[40] De Palma, G.D., et al., *Endoscopic management of intragastric penetrated adjustable gastric band for morbid obesity*. World J Gastroenterol, 2006. 12(25): p. 4098-100. [41] Weiss, H., et al., *Gastroscopic band removal after intragastric migration of adjustable gastric band: a new minimal invasive technique.* Obes Surg, 2000. 10(2): p. 167-70. [42] Caruana, J.A., et al., *Incidence of symptomatic gallstones after gastric bypass: is prophylactic* 

[43] Lopes, T.L. and T.H. Baron, *Endoscopic retrograde cholangiopancreatography in patients with* 

[44] Wright, B.E., O.W. Cass, and M.L. Freeman, *ERCP in patients with long-limb Roux-en-Y gastrojejunostomy and intact papilla.* Gastrointest Endosc, 2002. 56(2): p. 225-32. [45] Monkemuller, K., et al., *ERCP with the double balloon enteroscope in patients with Roux-en-*

[46] Parlak, E., et al., *Endoscopic retrograde cholangiography by double balloon enteroscopy in patients with Roux-en-Y hepaticojejunostomy*. Surg Endosc, 2010. 24(2): p. 466-70. [47] Moreels, T.G., et al., *Diagnostic and therapeutic double-balloon enteroscopy after small bowel* 

[48] Martinez, J., et al., *Endoscopic retrograde cholangiopancreatography and gastroduodenoscopy* 

[49] Lopes, T.L., R.H. Clements, and C.M. Wilcox, *Laparoscopy-assisted ERCP: experience of a* 

[50] Bertin, P.M., K. Singh, and M.E. Arregui, *Laparoscopic transgastric endoscopic retrograde* 

[53] Eubanks, S., et al., *Use of endoscopic stents to treat anastomotic complications after bariatric* 

[54] Manta, R., et al., *Endoscopic treatment of gastrointestinal fistulas using an over-the-scope clip (OTSC) device: Case series from a tertiary referral center.* Endoscopy, 2011. [55] Iacopini, F., et al., *Over-the-scope clip closure of two chronic fistulas after gastric band* 

[56] von Renteln, D., M.C. Vassiliou, and R.I. Rothstein, *Randomized controlled trial comparing* 

[57] Repici, A., et al., *Clinical experience with a new endoscopic over-the-scope clip system for use* 

[58] Ito, K., et al., *Percutaneous cholecystostomy versus gallbladder aspiration for acute* 

[59] Itoi, T., et al., *Endoscopic transpapillary gallbladder drainage in patients with acute* 

*endoscopic surgery gastrotomies.* Endoscopy, 2009. 41(12): p. 1056-61.

*endoscopic clips and over-the-scope clips for closure of natural orifice transluminal* 

*cholecystitis: a prospective randomized controlled trial.* AJR Am J Roentgenol, 2004.

*cholecystitis in whom percutaneous transhepatic approach is contraindicated or anatomically impossible (with video).* Gastrointest Endosc, 2008. 68(3): p. 455-60.

[51] Baker, R.S., et al., *The science of stapling and leaks*. Obes Surg, 2004. 14(10): p. 1290-8. [52] Edwards, C.A., et al., *Management of anastomotic leaks after Roux-en-Y bypass using self-*

*surgery.* J Am Coll Surg, 2008. 206(5): p. 935-8; discussion 938-9.

*penetration.* World J Gastroenterol, 2010. 16(13): p. 1665-9.

*in the GI tract.* Dig Liver Dis, 2009. 41(6): p. 406-10.

*high-volume bariatric surgery center (with video)*. Gastrointest Endosc, 2009. 70(6): p.

*cholangiopancreatography (ERCP) after gastric bypass: case series and a description of* 

*expanding polyester stents*. Surg Obes Relat Dis, 2008. 4(5): p. 594-9; discussion 599-

*Roux-en-Y reconstructive surgery*. Digestion, 2009. 80(3): p. 141-7.

*after Roux-en-Y gastric bypass.* Surg Endosc, 2006. 20(10): p. 1548-50.

*treatment really necessary?* Surg Obes Relat Dis, 2005. 1(6): p. 564-7; discussion 567-8.

*gastric band*. Gastrointest Endosc, 2004. 60(3): p. 480-1.

*Roux-en-Y anatomy.* J Hepatobiliary Pancreat Sci, 2010.

*Y anastomosis*. Surg Endosc, 2009. 23(9): p. 1961-7.


[18] Ommer, A., et al., [*Laparoscopic-assisted colonoscopic polypectomy--indications and results]*.

[19] Ludwig, K., et al., *Laparoscopic-endoscopic rendezvous resection of gastric tumors.* Surg

[20] Hiki, N., et al., *Laparoscopic and endoscopic cooperative surgery for gastrointestinal stromal* 

[21] Coimbra, C., et al., *Laparoscopic repair of colonoscopic perforation: a new standard?* Surg

[22] Senadhi, V., et al., *Combined colonoscopy and laparoscopy to close a colonic perforation*.

[23] Alexander, S., et al., *EMR of large, sessile, sporadic nonampullary duodenal adenomas:* 

[24] Abbass, R., J. Rigaux, and F.H. Al-Kawas, *Nonampullary duodenal polyps: characteristics and endoscopic management.* Gastrointest Endosc, 2010. 71(4): p. 754-9. [25] Sakon, M., et al., *A novel combined laparoscopic-endoscopic cooperative approach for duodenal* 

[26] Lanitis, S., et al., *Combined laparoscopic and endoscopic approach for the management of two* 

[27] Olson, J.A., Jr., L.B. Weinstock, and L.M. Brunt, *Combined endoscopic and laparoscopic* 

[28] Iafrati, M.D., et al., *A novel approach to the removal of sharp foreign bodies from the stomach* 

[29] Padwal, R., S.K. Li, and D.C. Lau, *Long-term pharmacotherapy for obesity and overweight.*

[30] Buchwald, H. and S.E. Williams, B*ariatric surgery worldwide 2003.* Obes Surg, 2004. 14(9):

[31] Podnos, Y.D., et al., *Complications after laparoscopic gastric bypass: a review of 3464 cases*.

[32] Msika, S., *[Surgery for morbid obesity: 2. Complications. Results of a Technologic Evaluation* 

[33] Kothari, S.N., et al., *Excellent laparoscopic gastric bypass outcomes can be achieved at a* 

[34] Peifer, K.J., et al., *Successful endoscopic management of gastrojejunal anastomotic strictures after Roux-en-Y gastric bypass*. Gastrointest Endosc, 2007. 66(2): p. 248-52. [35] Ukleja, A., et al., *Outcome of endoscopic balloon dilation of strictures after laparoscopic gastric* 

[36] Go, M.R., et al., *Endoscopic management of stomal stenosis after Roux-en-Y gastric bypass.* 

[37] Singhal, R., et al., *Band slippage and erosion after laparoscopic gastric banding: a meta-*

[38] Neto, M.P., et al., *Endoscopic removal of eroded adjustable gastric band: lessons learned after 5* 

*community-based training hospital with moderate case volume.* Ann Surg, 2010. 252(1): p.

*lesions.* J Laparoendosc Adv Surg Tech A, 2010. 20(6): p. 555-8.

Laparoendosc Adv Surg Tech A, 2007. 17(3): p. 311-4.

Cochrane Database Syst Rev, 2004(3): p. CD004094.

*by the ANAES]*. J Chir (Paris), 2003. 140(1): p. 4-21.

*bypass.* Surg Endosc, 2008. 22(8): p. 1746-50.

*analysis*. Surg Endosc, 2010. 24(12): p. 2980-6.

*years and 78 cases.* Surg Obes Relat Dis, 2010. 6(4): p. 423-7.

Surg Endosc, 2004. 18(1): p. 56-9.

Arch Surg, 2003. 138(9): p. 957-61.

*technical aspects and long-term outcome (with videos)*. Gastrointest Endosc, 2009. 69(1):

*ingested sewing needles: one migrated into the liver and one stuck in the duodenum*. J

*approach to remove a sharp gastric foreign body*. Gastrointest Endosc, 2000. 51(4 Pt 1): p.

*using a combined endoscopic and laparoscopic technique*. Gastrointest Endosc, 1996.

Zentralbl Chir, 2003. 128(3): p. 195-8.

Endoscopy, 2010. 42 Suppl 2: p. E213-4.

*tumor dissection.* Surg Endosc, 2008. 22(7): p. 1729-35.

Endosc, 2002. 16(11): p. 1561-5.

Endosc, 2010.

p. 66-73.

500-2.

43(1): p. 67-70.

p. 1157-64.

43-9.


[60] Comin, J.M., R.J. Cade, and A.F. Little, P*ercutaneous cystic duct stent placement in the treatment of acute cholecystitis.* J Med Imaging Radiat Oncol, 2010. 54(5): p. 457-61. [61] Mutignani, M., et al., *Endoscopic gallbladder drainage for acute cholecystitis: technical and* 

[62] Chen, D., et al., *Systematic review of endoscopic treatments for gastro-oesophageal reflux* 

[63] Romagnuolo, J., *Endoscopic "antireflux" procedures: not yet ready for prime time.* Can J

[64] Thomson, M., et al., *Endoluminal gastroplication in children with significant gastro-*

[65] Chuttani, R., et al., *A novel endoscopic full-thickness plicator for the treatment of GERD: A* 

[66] Schiefke, I., et al., *Use of an endoscopic suturing device (the "ESD") to treat patients with* 

[67] Wong, R.F., T.V. Davis, and K.A. Peterson, C*omplications involving the mediastinum after injection of Enteryx for GERD*. Gastrointest Endosc, 2005. 61(6): p. 753-6. [68] Veerappan, G.R., J.M. Koff, and M.T. Smith, *Enteryx polymer migration to lymph nodes and* 

[69] Noh, K.W., et al., *Pneumomediastinum following Enteryx injection for the treatment of gastroesophageal reflux disease.* Am J Gastroenterol, 2005. 100(3): p. 723-6. [70] Urbach, D.R., et al., *A decision analysis of the optimal initial approach to achalasia:* 

[71] Pasricha, P.J., et al., *Submucosal endoscopic esophageal myotomy: a novel experimental approach for the treatment of achalasia*. Endoscopy, 2007. 39(9): p. 761-4. [72] Inoue, H., et al., *Peroral endoscopic myotomy (POEM) for esophageal achalasia.* Endoscopy,

[73] Stavropoulos, S.N., et al., *Endoscopic submucosal myotomy for the treatment of achalasia* 

*(with video)*. Gastrointest Endosc, 2010. 72(6): p. 1309-11.

*gastroesophageal reflux disease, after unsuccessful EndoCinch endoluminal gastroplication:* 

*laparoscopic Heller myotomy with partial fundoplication, thoracoscopic Heller myotomy, pneumatic dilatation, or botulinum toxin injection*. J Gastrointest Surg, 2001. 5(2): p.

*clinical results.* Endoscopy, 2009. 41(6): p. 539-46.

*oesophageal reflux disease*. Gut, 2004. 53(12): p. 1745-50.

*pilot study.* Gastrointest Endosc, 2003. 58(5): p. 770-6.

*another failure.* Endoscopy, 2005. 37(8): p. 700-5.

*beyond.* Endoscopy, 2008. 40 Suppl 2: p. E10-1.

192-205.

2010. 42(4): p. 265-71.

*disease.* Br J Surg, 2009. 96(2): p. 128-36.

Gastroenterol, 2004. 18(9): p. 573-7.
